Stock Events

Stock Events

IBEX Technologies 

$1.0519
3
+$0.05+5.19%Friday 17:15

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
9.09
Dividend Yield
-
Dividend
-

Earnings

Nov 10Expected
Q4 2020
Q1 2021
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q3 2022
0
0.01
0.01
0.02
Expected EPS
N/A
Actual EPS
0.0205

Financials

35.32%Profit Margin
Unprofitable
2018
2019
2020
2021
2022
2023
-98,355.2Revenue
-34,743.22Net Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Bio-Techne
TECH
Mkt Cap11.35B
Bio-Techne Corporation manufactures and sells biotechnology products and clinical diagnostic controls which overlap with the enzyme and diagnostic solutions provided by IBEX Technologies.
Qiagen NV
QGEN
Mkt Cap9.24B
Qiagen N.V. provides sample and assay technologies which are used in extracting, purifying, amplifying, and interpreting DNA, RNA, and proteins, similar to IBEX's offerings in enzyme-related technologies.
Neogenomics
NEO
Mkt Cap2.37B
Bio-Rad Laboratories
BIO
Mkt Cap9.87B
Bio-Rad Laboratories, Inc. produces and supplies products and systems used for the life science research and clinical diagnostics, competing directly in the diagnostics sector.
Thermo Fisher Scientific
TMO
Mkt Cap242.11B
Thermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, analysis, discovery, and diagnostics, overlapping with IBEX's market.
Quest Diagnostics
DGX
Mkt Cap25.75B
Quest Diagnostics Incorporated offers diagnostic testing services, including routine testing and esoteric genetic testing, directly competing with IBEX's diagnostic products.
Repligen
RGEN
Mkt Cap10.25B
Repligen Corporation provides bioprocessing technologies and systems that are used in biological drug manufacturing, including protein production which is a key area for IBEX.
Guardant Health
GH
Mkt Cap23.86B
Guardant Health, Inc. focuses on helping conquer cancer globally through use of its proprietary blood tests, vast data sets, and advanced analytics, sharing the diagnostics and research market with IBEX.

About

Pharmaceuticals: Other
Health Technology
Biotechnology
IBEX Technologies Inc., through its subsidiaries, manufactures and markets enzymes for biomedical use in Canada, the United States, Germany, the United Kingdom, and internationally. It offers a portfolio of recombinant glycosaminoglycan lyases, including Heparinase I, Heparinase II, Heparinase III, Chondroitinase AC, and Chondroitinase B; collagen ELISAs for the study of synthesis and degradation of connective tissue components; collagen antibodies; and diamine oxidase liquid. The company also manufactures and markets a range of arthritis assays, which are used in osteoarthritis research. In addition, it provides lyophilization services for making disposable medical device components; and custom fermentation and contract manufacturing services. It serves manufacturers of medical devices, quality control labs, low molecular weight heparin manufacturers, and academic research institutions. IBEX Technologies Inc. was incorporated in 1972 and is based in Montreal, Canada.
Show More
CEO
Country
Canada
ISIN
CA4489375085
WKN
000883396

Listings

0 Comments

Share your thoughts

FAQs

What is IBEX Technologies stock price today?▼
The current price of IBXNF is $1.05 USD — it has increased by +5.19% in the past 24 hours. Watch IBEX Technologies stock price performance more closely on the chart.
What is IBEX Technologies stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTCM exchange IBEX Technologies stocks are traded under the ticker IBXNF.
What were IBEX Technologies earnings last quarter?▼
IBXNF earnings for the last quarter are 0.02 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is IBEX Technologies revenue for the last year?▼
IBEX Technologies revenue for the last year amounts to -98,355.2 USD.
What is IBEX Technologies net income for the last year?▼
IBXNF net income for the last year is -34,743.22 USD.
In which sector is IBEX Technologies located?▼
IBEX Technologies operates in the Technology sector.
When did IBEX Technologies complete a stock split?▼
IBEX Technologies has not had any recent stock splits.
Where is IBEX Technologies headquartered?▼
IBEX Technologies is headquartered in Mississauga, Canada.